Health Management Center, The Affiliated Hospital of Qingdao University, Qingdao, China.
Deapartment of Neurology, Jinan Central Hospital Affiliated to Shandong First Medical University, Jinan, China.
Eur Radiol. 2023 Mar;33(3):2160-2170. doi: 10.1007/s00330-022-09168-6. Epub 2022 Oct 12.
To construct and validate a contrast-enhanced computed tomography (CECT)-based radiomics nomogram to predict Ki-67 expression level in head and neck squamous cell carcinoma (HNSCC).
A total of 217 patients with HNSCC who underwent CECT scans and immunohistochemical examination of their Ki-67 index were enrolled in this study. The patients were divided into a training set (n = 140; Ki-67: ≥ 50% [n = 72] and < 50% [n = 68]) and an external test set (n = 77; Ki-67: ≥ 50% [n = 38] and < 50% [n = 39]). The least absolute shrinkage and selection operator method was used to select key features for a CECT-image-based radiomics signature and a radiomics score (Rad-score) was calculated. A clinical model was established using clinical data and CT findings. The independent clinical factors and Rad-score were then combined to construct a radiomics nomogram. The performance characteristics of the Rad-score, clinical model, and nomogram were assessed using ROCs and decision curve analysis.
Twenty features were finally selected to construct the Rad-score. The radiomics nomogram incorporating the Rad-score, low histological grade, and lymphatic spread showed higher predictive value for the Ki-67 index (≥ 50% vs. < 50%) than the clinical model on both the training (AUC, 0.919 vs. 0.648, p < 0.001) and test (AUC, 0.832 vs. 0.685, p = 0.030) sets. Decision curve analysis demonstrated that the radiomics nomogram was more clinically useful than the clinical model.
A CECT-based radiomics nomogram was constructed to predict the expression of Ki-67 in HNSCC. This model showed favorable predictive efficacy and might be useful for prognostic evaluation and clinical decision-making in patients with HNSCC.
• Accurate pre-treatment prediction of Ki-67 index in HNSCC is crucial. • A CECT-based radiomics nomogram showed favorable predictive efficacy in estimation of Ki-67 expression status in HNSCC patients.
构建并验证基于增强 CT(CECT)的放射组学列线图,以预测头颈部鳞状细胞癌(HNSCC)中 Ki-67 的表达水平。
本研究共纳入 217 例接受 CECT 扫描和 Ki-67 免疫组化检查的 HNSCC 患者。将患者分为训练集(n=140;Ki-67:≥50%[n=72]和<50%[n=68])和外部测试集(n=77;Ki-67:≥50%[n=38]和<50%[n=39])。采用最小绝对收缩和选择算子方法选择 CECT 图像的关键特征,并计算放射组学评分(Rad-score)。使用临床数据和 CT 结果建立临床模型。然后将独立的临床因素和 Rad-score 结合起来构建放射组学列线图。使用 ROC 和决策曲线分析评估 Rad-score、临床模型和列线图的性能特征。
最终选择了 20 个特征来构建 Rad-score。包含 Rad-score、低组织学分级和淋巴扩散的放射组学列线图在训练集(AUC,0.919 对 0.648,p<0.001)和测试集(AUC,0.832 对 0.685,p=0.030)上对 Ki-67 指数(≥50%对<50%)的预测价值均高于临床模型。决策曲线分析表明,放射组学列线图比临床模型更具临床实用性。
构建了基于 CECT 的放射组学列线图来预测 HNSCC 中 Ki-67 的表达。该模型显示出良好的预测效果,可能有助于 HNSCC 患者的预后评估和临床决策。
• 准确预测 HNSCC 中 Ki-67 指数对于治疗前的决策至关重要。• 基于 CECT 的放射组学列线图在预测 HNSCC 患者 Ki-67 表达状态方面具有良好的预测效果。